Our Pharmaceuticals business unit has three main strategic areas of sustainability focus: improving global health through more affordable access to our medicines and by expanding research and development for medicines for neglected tropical diseases; reducing the environmental impacts of pharmaceutical product development, manufacture, use and end-of-life management; and securing a more transparent, responsible, efficient and innovative supply chain.